These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 3908277

  • 1. Improvement of insulin action is an important part of the antidiabetic effect of metformin.
    Schernthaner G.
    Horm Metab Res Suppl; 1985; 15():116-20. PubMed ID: 3908277
    [Abstract] [Full Text] [Related]

  • 2. Membrane physiology as a basis for the cellular effects of metformin in insulin resistance and diabetes.
    Wiernsperger NF.
    Diabetes Metab; 1999 Jun; 25(2):110-27. PubMed ID: 10443322
    [Abstract] [Full Text] [Related]

  • 3. [Action of metformin at and beyond insulin receptors. Studies in humans].
    Joffroy-Lavieuville M, Noël M.
    Journ Annu Diabetol Hotel Dieu; 1983 Jun; ():281-6. PubMed ID: 6358619
    [No Abstract] [Full Text] [Related]

  • 4. Metformin and insulin receptors.
    Vigneri R, Gullo D, Pezzino V.
    Diabetes Care; 1984 Jun; 7 Suppl 1():113-7. PubMed ID: 6376023
    [Abstract] [Full Text] [Related]

  • 5. [Biguanides and glucidic homeostasis: effects of metformin and phenformin on the intermediate metabolism and insulin receptors of normal subjects].
    Calafiore R, Pietropaolo M, Basta G, Calcinaro F.
    Recenti Prog Med; 1985 Mar; 76(3):152-3. PubMed ID: 3892607
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G, Maffioli P, Salvadeo SA, Ferrari I, Gravina A, Mereu R, Palumbo I, D'Angelo A, Cicero AF.
    Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
    [Abstract] [Full Text] [Related]

  • 10. Metformin enhances insulin binding to "in vitro" down regulated human fat cells.
    Cigolini M, Zancanaro C, Benati D, Cavallo E, Bosello O, Smith U.
    Diabete Metab; 1987 Feb; 13(1):20-2. PubMed ID: 3552772
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of alloxan diabetes and phenformin on insulin binding with liver plasma membrane receptors.
    Chaujar M, Chaudhuri BN, Yadav HS, Chauhan UP.
    Jpn J Exp Med; 1984 Oct; 54(5):189-93. PubMed ID: 6398835
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of metformin on insulin-stimulated tyrosine kinase activity of erythrocytes from obese women with normal glucose tolerance.
    Santos RF, Nomizo R, Bopsco A, Wajchenberg BL, Reaven GM, Azhar S.
    Diabetes Metab; 1997 Apr; 23(2):143-8. PubMed ID: 9137903
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the in vitro effect of biguanides and sulfonylureas on insulin binding of its receptors in target cells.
    Vigneri R, Pezzino V, Wong KY, Goldfine ID.
    J Clin Endocrinol Metab; 1982 Jan; 54(1):95-100. PubMed ID: 7033271
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.